Andrew M. Posselt, MD, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Andrew M. Posselt, MD, PhD

Professor, Department of Surgery, UCSF; Surgeon, Pancreatic Islet Transplantation and Liver Transplant Programs

Phone: (415) 353-1888 (appts)
Box 1780, UCSF
San Francisco, CA 94143-1780

View on UCSF Profiles

Selected Publications

  1. Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status. J Bone Miner Res. 2015 Aug; 30(8):1377-85.
    View on PubMed
  2. Autologous islet transplantation with remote islet isolation after pancreas resection for chronic pancreatitis. JAMA Surg. 2015 Feb 1; 150(2):118-24.
    View on PubMed
  3. Changes in vertebral bone marrow fat and bone mass after gastric bypass surgery: A pilot study. Bone. 2015 May; 74:140-5.
    View on PubMed
  4. Islet transplantation for Type 1 diabetes: where are we now? Expert Rev Clin Immunol. 2015 Jan; 11(1):59-68.
    View on PubMed
  5. Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999-2010. Am J Transplant. 2014 Nov; 14(11):2595-606.
    View on PubMed
  6. Human islet viability and function is maintained during high-density shipment in silicone rubber membrane vessels. Transplant Proc. 2014 Jul-Aug; 46(6):1989-91.
    View on PubMed
  7. Predictors of hospital stay following laparoscopic gastric bypass: analysis of 9,593 patients from the National Surgical Quality Improvement Program. Surg Obes Relat Dis. 2015 Mar-Apr; 11(2):288-94.
    View on PubMed
  8. Combined pancreatic islet and kidney transplantation in a child with unstable type 1 diabetes and end-stage renal disease. Am J Transplant. 2013 Aug; 13(8):2207-10.
    View on PubMed
  9. Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis. 2013 Sep-Oct; 9(5):653-8.
    View on PubMed
  10. Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care. 2012 Jul; 35(7):1436-45.
    View on PubMed
  11. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg Endosc. 2013 Jan; 27(1):81-5.
    View on PubMed
  12. Islet Transplantation & ß-Cell Replacement Therapies for Diabetes. J Transplant. 2011; 2011:157840.
    View on PubMed
  13. Experience with laparoscopic donor nephrectomy among more than 1000 cases: low complication rates, despite more challenging cases. Arch Surg. 2011 Jul; 146(7):859-64.
    View on PubMed
  14. Early and late abdominal bleeding after Roux-en-Y gastric bypass: sources and tailored therapeutic strategies. Obes Surg. 2011 Apr; 21(4):413-20.
    View on PubMed
  15. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Transplantation. 2010 Dec 27; 90(12):1595-601.
    View on PubMed
  16. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. Am J Transplant. 2010 Aug; 10(8):1870-80.
    View on PubMed
  17. Clinical islet transplantation at the University of California, San Francisco. Clin Transpl. 2010; 235-43.
    View on PubMed
  18. Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease. Transplantation. 2009 Sep 27; 88(6):753-6.
    View on PubMed
  19. Portomesenteric venous thrombosis after laparoscopic surgery: a systematic literature review. Arch Surg. 2009 Jun; 144(6):520-6.
    View on PubMed
  20. Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol. 2009 Jul; 4(7):1230-8.
    View on PubMed

Go to UCSF Profiles, powered by CTSI